Equine infectious anemia

From WikiMD's WELLNESSPEDIA

(Redirected from Coggins test)

A viral disease affecting horses

File:Cogginstest.JPG
A Coggins test form used to diagnose Equine Infectious Anemia

Equine Infectious Anemia (EIA) is a viral disease that affects horses and other members of the Equidae family. It is caused by the Equine infectious anemia virus (EIAV), which is a member of the Retroviridae family, specifically a lentivirus.

Transmission[edit]

EIA is primarily transmitted through the transfer of blood from an infected horse to a healthy horse. This can occur through the use of contaminated needles, syringes, or surgical instruments. Additionally, the virus can be spread by blood-feeding insects such as horseflies and deer flies.

Symptoms[edit]

Horses infected with EIA may exhibit a range of symptoms, which can vary in severity. Common symptoms include:

  • Fever
  • Depression
  • Weight loss
  • Anemia
  • Swelling of the legs and lower chest

In some cases, horses may become carriers of the virus without showing any clinical signs, posing a risk of transmission to other horses.

Diagnosis[edit]

The most common method for diagnosing EIA is the Coggins test, a serological test that detects antibodies to the virus in the horse's blood. The test is named after Dr. Leroy Coggins, who developed it in the 1970s. A positive Coggins test indicates that the horse is infected with EIA.

Prevention and Control[edit]

Preventing the spread of EIA involves several strategies:

  • Regular testing of horses using the Coggins test
  • Quarantine and isolation of infected animals
  • Use of sterile needles and equipment
  • Control of blood-feeding insects

There is currently no vaccine available for EIA, and infected horses may need to be euthanized or permanently isolated to prevent transmission.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.